The Insider Activity Of Cosmos Health Inc. (COSM) Should Not Be Ignored

As of Thursday close, Cosmos Health Inc.’s (NASDAQ:COSM) stock was up $0.23, moving up 14.94 percent to $1.77. The average number of shares traded per day over the past five days has been 2,249,860 shares. 2 times new highs have been achieved over the past 5 days, with a $0.4800 gain in that time frame. In the last twenty days, the average volume was 3,294,935, while in the previous 50 days, it was 1,868,388.

Since last month, COSM stock rose 36.15%. Shares of the company fell to $0.9900 on 09/11/23, the lowest level in the past month. A 52-week high of $23.84 was reached on 01/26/23 after having rallying from a 52-week low of $0.99. Since the beginning of this year, COSM’s stock price has dropped by -61.18% or -$2.7900, and marked a new high 5 times. However, the stock has declined by -92.58% since its 52-week high.

COSM stock investors should be aware that Cosmos Health Inc. (COSM) stock had its last reported insider trading activity 64 days ago on Jul 20. Siokas Grigorios, the Chief Executive Officer of the company, purchased of 181,451 shares for $2.48 on Jul 20. It resulted in a $449,998 investment by the insider. Siokas Grigorios added 4,474 shares at an average price of $23.92 on Jun 06. The insider now owns 1,146,434 shares following the transaction. On Apr 27, Chief Executive Officer Siokas Grigorios bought 4,474 shares at $24.64 apiece. The transaction was valued at $110,239.

Valuation Metrics

The stock’s beta is 2.94. Besides these, the trailing price-to-sales (P/S) ratio of 0.44, the price-to-book (PB) ratio of 0.44.

Financial Health

In the recent quarter, Cosmos Health Inc.’s quick ratio stood at 1.90, while its current ratio was 2.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the recent quarter was 0.06, and the total debt-to-equity ratio was 0.20. On the profitability front, the trailing twelve-month gross margin is 8.50% percent. In the recent year, EBITDA margin amounted to -14.47%, whereas operating margins totaled -19.40%. Based on annual data, COSM earned $5.96 million in gross profit and brought in $50.35 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -14.30%. Return on equity (ROE) for the past 12 months was -127.40%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. COSM’s revenue fell -6.88% to $12.35 million during the quarter, while net income inched up to $12.36 million. During the quarter, the company generated -$2.45 million in EBITDA. The liabilities of Cosmos Health Inc. were 24.92 million at the end of its most recent quarter, and its total debt was $9.46 million. The value of shareholders’ equity is $10.62 million.

Technical Picture

This quick technical analysis looks at Cosmos Health Inc.’s (COSM) price momentum. With a historical volatility rate of 192.51%, the RSI 9-day stood at 72.02% on 21 September.

With respect to its five-day moving average, the current Cosmos Health Inc. price is up by +37.21% percent or $0.4800. At present, COSM shares trade +36.15% above its 20-day simple moving average and -47.48% percent below its 100-day simple moving average. However, the stock is currently trading approximately -44.16% below its SMA50 and -86.77% below its SMA200.

Stochastic coefficient K was 70.55% and Stochastic coefficient D was 67.35%, while ATR was 0.2181. Given the Stochastic reading of 89.72% for the 14-day period, the RSI (14) reading has been calculated as 64.06%. As of today, the MACD Oscillator reading stands at 0.1833, while the 14-day reading stands at 0.2762.

Analyst Ratings

Cosmos Health Inc. (COSM) has been rated – by analysts. According to 0 brokerage firms, COSM is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Cosmos Health Inc. stock as buy, with 0 recommending it as overweight.

Most Popular

Related Posts